Effect of transforming growth factor-β1 on gene expression of extracellular matrix components in orbital fibroblasts with thyroid-associated ophthalmopathy

Wei Rui,Zhang Peng

2011-01-01

Abstract:Objective To investigate the effects of transforming growth factor-β1(TGF-β1) on gene expression of main components of extracellular matrix including tissue inhibitions of metalloproteinase-1(TIMP-1),collagen type-I(COL-I),COL-Ⅲ and fibronectin(FN) in orbital fibroblasts(OF) of patients with thyroid-associated ophthalmopathy(TAO). Methods OF were treated with 10 μg·L-1 TGF-β1 at different time points(0 hour,3 hours,6 hours,12 hours,24 hours and 48 hours) and different concentrations(1 μg·L-1,5 μg·L-1,10 μg·L-1 and 20 μg·L-1) of TGF-β1 for 24 hours,and real-time quantitative RT-PCR was performed to observe the effects of TGF-β1 on the expression of TIMP-1,COL-Ⅰ,COL-Ⅲ and FN mRNA. Results Time effect of OF treated with 10 μg·L-1 TGF-β1:TIMP-1 mRNA was 1.5 folds to that of control group at 3 hours and 2.46 folds at 6 hours(both P0.01);COL-I mRNA was 5.49 folds to that of control group at 24 hours and 3.69 folds at 48 hours(both P0.01);COL-Ⅲ mRNA was 2.14 folds to that of control group at 24 hours and 1.63 folds at 48 hours(both P0.01);FN mRNA was 2.45 folds to that of control group at 12 hours and 1.53 folds at 24 hours(both P0.01);Dose effects of OF treated with different concentrations TGF-β1 for 24 hours:TIMP-1 mRNA was 1.79 folds to that of control group at 5 μg·L-1 and 1.46 folds at 10 μg·L-1(both P0.01);COL-I mRNA was 1.94 folds to that of control group at 1 μg·L-1 and 3.29 folds at 10 μg·L-1(both P0.01);COL-Ⅲ mRNA was 1.52 folds to that of control group at 5 μg·L-1 and 3.28 folds at 10 μg·L-1(both P0.01);FN mRNA was 1.30 folds to that of control group at 1 μg·L-1 and 2.45 folds at 10 μg·L-1(both P0.01). Conclusions TGF-β1 can stimulate the expression of TIMP-1,COL-Ⅰ,COL-Ⅲ and FN in OF in a time and dose-dependent manner.It may play an important role in the pathogenesis of extraocular muscle fibrosis with TAO.